UCMOK
BMY icon

United Capital Management of KS’s Bristol-Myers Squibb BMY Stock Holding History

United Capital Management of KS’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-59,574
Closed -$3.81M – 74
2023
Q2 		$3.81M Buy
59,574
+727
+1% +$48.8K 1.22% 32
2023
Q1 		$4.08M Buy
58,847
+948
+2% +$66.9K 1.52% 24
2022
Q4 		$4.17M Sell
57,899
-1,783
-3% -$134K 1.72% 22
2022
Q3 		$4.24M Buy
59,682
+40
+0.1% +$2.9K 1.99% 16
2022
Q2 		$4.59M Sell
59,642
-1,529
-2% -$116K 2.16% 11
2022
Q1 		$4.47M Sell
61,171
-1,370
-2% -$92K 1.73% 21
2021
Q4 		$3.9M Buy
62,541
+6,942
+12% +$407K 1.45% 31
2021
Q3 		$3.29M Buy
55,599
+4,673
+9% +$308K 1.35% 33
2021
Q2 		$3.4M Buy
50,926
+3,259
+7% +$213K 1.39% 28
2021
Q1 		$3.01M Buy
47,667
+2,429
+5% +$151K 1.38% 28
2020
Q4 		$2.81M Buy
45,238
+2,598
+6% +$160K 1.28% 31
2020
Q3 		$2.57M Buy
42,640
+4,559
+12% +$274K 1.35% 29
2020
Q2 		$2.24M Buy
38,081
+15,289
+67% +$914K 1.31% 31
2020
Q1 		$1.27M Buy
22,792
+4,406
+24% +$269K 1.07% 35
2019
Q4 		$1.18M Buy
18,386
+1,211
+7% +$69.4K 0.75% 48
2019
Q3 		$874K Buy
17,175
+2,365
+16% +$111K 0.64% 51
2019
Q2 		$684K Buy
14,810
+1,275
+9% +$59.4K 0.52% 61
2019
Q1 		$604K Buy
13,535
+3,436
+34% +$171K 0.47% 65
2018
Q4 		$525K Buy
10,099
+1,624
+19% +$87.3K 0.49% 66
2018
Q3 		$515K Buy
+8,475
New +$503K 0.41% 71

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

United Capital Management of KS's BMY Position: Q3 2023 in Review

United Capital Management of KS sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 59,574 shares — an estimated $3.81M sold.

United Capital Management of KS first reported a position in BMY in Q3 2018 and held it in 20 quarters. The position peaked at $4.59M in Q2 2022. 2,389 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • United Capital Management of KS reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • United Capital Management of KS sold 59,574 Bristol-Myers Squibb shares in Q3 2023, an estimated $3.81M.
  • United Capital Management of KS first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 20 quarters.
  • United Capital Management of KS's Bristol-Myers Squibb position peaked at $4.59M in Q2 2022.
  • 2,389 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on United Capital Management of KS's 13F filing for Q3 2023, filed 3 Nov 2023.